Austco Healthcare (AHC) Fundamentals 2026 — P/E 11.2x, Revenue Analysis | SniperIQ
Austco Healthcare (AHC) is a AU-listed Healthcare company in Medical - Instruments & Supplies with a market capitalization of A$88M, trading at A$0.23 on the ASX. This SniperIQ fundamentals page covers Austco Healthcare's valuation (P/E 11.2x, P/B 1.5x), profitability (net margin 8.4%), revenue (A$81M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Austco Healthcare's market cap?
Austco Healthcare (AHC) has a market capitalization of approximately A$88M, trading at A$0.23 on the ASX. Market cap moves with the live share price.
What is Austco Healthcare's P/E ratio?
Austco Healthcare's trailing twelve-month P/E ratio is 11.2x, with a price-to-book (P/B) of 1.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Austco Healthcare?
Austco Healthcare runs a net profit margin of 8.4%, a gross margin of 37.6%, and an operating margin of 11.9%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Austco Healthcare generate?
Austco Healthcare reported revenue of A$81M for fiscal year 2025, with net income of A$6M and earnings per share (EPS) of 0.0163. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Austco Healthcare pay a dividend?
Austco Healthcare does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Austco Healthcare financially healthy?
Austco Healthcare carries a debt-to-equity ratio of 0.13x and a current ratio of 2.15x, with a market beta of 0.32. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Austco Healthcare a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Austco Healthcare (AHC) the key facts are: market cap A$88M, P/E 11.2x, revenue A$81M, 52-week range 0.1925-0.445. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Austco Healthcare's full fundamentals live
Get Austco Healthcare's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.